Calamos Advisors
AUGX

Calamos Advisors’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Calamos Advisors’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-151,494
Closed -$886K – 1046
2023
Q4 		$886K Buy
+151,494
New +$797K ﹤0.01% 678

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Calamos Advisors's AUGX Position: Q1 2024 in Review

Calamos Advisors sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2024, closing a stake of 151,494 shares — an estimated $886K sold.

Calamos Advisors first reported a position in AUGX in Q4 2023 and held it in 1 quarter. The position peaked at $886K in Q4 2023. 84 funds tracked by Wall St. Rank hold AUGX as of Q1 2024.

  • Calamos Advisors reported no remaining Augmedix, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Calamos Advisors sold 151,494 Augmedix, Inc. Common Stock shares in Q1 2024, an estimated $886K.
  • Calamos Advisors first reported a position in Augmedix, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Calamos Advisors's Augmedix, Inc. Common Stock position peaked at $886K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2024.

Based on Calamos Advisors's 13F filing for Q1 2024, filed 8 May 2024.